| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.23 | 7e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 6e-07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |